1'-acetoxychavicol acetate has been researched along with Malignant Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagihara, K; Kita, A; Kunoh, T; Manse, Y; Masuko, T; Matsuura, K; Moriyama, H; Moriyama, M; Muraoka, O; Satoh, R; Sugiura, R; Tanabe, G | 1 |
1 other study(ies) available for 1'-acetoxychavicol acetate and Malignant Melanoma
Article | Year |
---|---|
Identification of ACA-28, a 1'-acetoxychavicol acetate analogue compound, as a novel modulator of ERK MAPK signaling, which preferentially kills human melanoma cells.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Benzyl Alcohols; Butadienes; Cell Line, Tumor; Cell Transformation, Neoplastic; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Humans; MAP Kinase Kinase 1; Melanocytes; Melanoma; Mice; Nitriles; Phosphorylation; Signal Transduction | 2017 |